Heritability and shared environmental effects of brain diseases in 12,040 extended families
Brain diseases have complex patterns of genetic and environmental risk factors, and better understanding of these risks is required for more effective prevention strategies. Participants of the Dutch Brain Research Registry provided detailed information on family structure and occurrence of brain diseases. A total of 12,040 participants (73% female, aged 64.9 ± 11 years) provided information on 101,379 family members (53% female, aged 62 ± 25 years). We estimated heritability (<i>h</i> <sup>2</sup>) of the nine most common brain diseases using polygenic modeling in SOLAR and assessed variations in <i>h</i> <sup>2</sup> through bootstrapping; Alzheimer's disease (AD) (<i>h</i> <sup>2</sup> = 73, range 53-86, <i>P</i> <sub>fdr</sub> < 0.001), ALS (<i>h</i> <sup>2</sup> = 72, range 10-98, <i>P</i> <sub>fdr</sub> = 0.030), frontotemporal dementia (FTD) (<i>h</i> <sup>2</sup> = 48, range 0-97, <i>P</i> <sub>fdr</sub> = 0.132), vascular dementia (VaD) (<i>h</i> <sup>2</sup> = 41, range 7-64, <i>P</i> = 0.003), Lewy Body dementia (<i>h</i> <sup>2</sup> = 34, range 0-58, <i>P</i> = 0.132), iCVA (<i>h</i> <sup>2</sup> = 27, 6-59, <i>P</i> <sub>fdr</sub> = 0.013), hCVA (<i>h</i> <sup>2</sup> = 29, 8-57, <i>P</i> <sub>fdr</sub> = 0.007), Parkinson's disease (PD) (<i>h</i> <sup>2</sup> = 38, 6-66, <i>P</i> <sub>fdr</sub> = 0.013), and multiple sclerosis (<i>h</i> <sup>2</sup> = 10, 10-97, <i>P</i> <sub>fdr</sub> < 0.001). Shared environmental effects could be estimated for AD (<i>c</i> <sup>2</sup> = 5.8%, <i>P</i> <sub>fdr</sub> = 0.011), VaD (<i>c</i> <sup>2</sup> = 9.0%, <i>P</i> <sub>fdr</sub> = 0.021), FTD (<i>c</i> <sup>2</sup> = 9.7%, <i>P</i> <sub>fdr</sub> = 0.33), iCVA (<i>c</i> <sup>2</sup> = 15.9%, <i>P</i> <sub>fdr</sub> < 0.001), hCVA (<i>c</i> <sup>2</sup> = 14.9%, <i>P</i> <sub>fdr</sub> = 0.005), and PD (<i>c</i> <sup>2</sup> = 7.5%, <i>P</i> <sub>fdr</sub> = 0.25). These findings underscore the significance of genetic contribution to most brain diseases and the important role of shared environments in AD and vascular-related conditions, highlighting initiatives to mitigate modifiable risk factors.
Authors
- Lisa Vermunt (ORCID: https://orcid.org/0000-0001-7420-6384)
- Marc Hulsman (ORCID: https://orcid.org/0000-0002-9889-3606)
- Peter Kochunov (ORCID: https://orcid.org/0000-0003-3656-4281)
- Brian Donohue
- Henne Holstege (ORCID: https://orcid.org/0000-0002-7688-3087)
- Anouk den Braber (ORCID: https://orcid.org/0000-0002-3377-2627)
- Lisa Waterink (ORCID: https://orcid.org/0009-0002-5469-4098)
- Janna I.R. Dijkstra (ORCID: https://orcid.org/0000-0003-3673-2513)
- Charlotte Elisabeth Teunissen (ORCID: https://orcid.org/0000-0002-4061-0837)
- Marissa D. Zwan (ORCID: https://orcid.org/0000-0003-0879-2164)
- Bryan A. de Jong
- Sven J. van der Lee
- Wouter F. L. Christiaansen
Institutions
- University of Maryland, Baltimore (US)
- Amsterdam Neuroscience (NL)
- Amsterdam University Medical Centers (NL)
- University of Baltimore (US)
- Vrije Universiteit Amsterdam (NL)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- npj Dementia
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1038/s44400-025-00030-2
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- Health~Holland
- Amsterdam University Medical Centers
- ZonMw
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Hersenstichting
- Stichting Dioraphte
- Alzheimer Nederland
- Amsterdam Neuroscience